Targeted Therapy for Pulmonary Hypertension in Premature Infants

Targeted Therapy for Pulmonary Hypertension in Premature Infants

Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, the...

Full description

Bibliographic Details
Main Authors: Shannon N Nees, Erika B Rosenzweig, Jennifer L Cohen, Gerson A Valencia Villeda, Usha S Krishnan
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Children
Subjects:
pulmonary hypertension
prematurity
bronchopulmonary dysplasia
Online Access:https://www.mdpi.com/2227-9067/7/8/97

Internet

https://www.mdpi.com/2227-9067/7/8/97

Similar Items